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Homograft valve repair for recurrent prosthetic valve endocarditis
Richard Lee, MD, and Marc R. Moon, MD, St Louis, Mo
Surgical management of prosthetic valve endocarditis(PVE) remains a formidable challenge, especially forpatients who continue intravenous drug use after suc-cessful initial treatment.1,2 In an effort to reduce the rate
of recurrent endocarditis, strategies including aortic valve repair
and aortic root replacement with a homograft have been report-
ed.1,3 However, recurrent endocarditis of an aortic homograft
represents a clinical problem without a well-established solution.
This report details the treatment of a second recurrence of PVE in
an intravenous drug user who had undergone homograft root
replacement 11 months previously for endocarditis of an aortic
valve bioprosthesis.
Clinical Summary
A 43-year-old woman with diabetes mellitus and a 25-year history
of intravenous drug use was seen in June 2000 with a history of
fever, chills, and a cough for several weeks. Blood cultures re-
vealed Streptococcus sanguis. Transthoracic echocardiography re-
vealed severe aortic insufficiency and a large vegetation on the
noncoronary cusp of the valve. The development of severe con-
gestive heart failure necessitated aortic valve replacement. At the
operation, the noncoronary cusp was completely destroyed but the
annulus was spared, so a bioprosthetic valve was inserted.4 After
the operation the patient received 4 weeks of organism-specific
antibiotic therapy and was discharged to a drug rehabilitation
center.
Three months later (September 2000), she was seen with fever
and chills after resumption of intravenous drug use. Transesoph-
ageal echocardiography demonstrated no vegetations or abscesses.
Blood cultures revealed Staphylococcus aureus. Initially, the pa-
tient was treated with intravenous vancomycin; however, she re-
fused to return to a drug rehabilitation center and was discharged
against medical advice with an oral course of antibiotics.
Three months later (December 2000), she returned in severe
congestive heart failure with a perivalvular leak and an extensive
aortic root abscess that involved more than half of the annulus.
Aortic root replacement was therefore performed with an aortic
homograft. She did well postoperatively and agreed to go to an
extended care facility for further antibiotic treatment.
Eleven months later (November 2001), she was seen again with
fever and chills, again after resumption of intravenous drug use.
Transesophageal echocardiography revealed a 1.5-cm vegetation
on the left coronary cusp of her aortic homograft valve (Figure 1).
Blood cultures revealed Streptococcus mitis. Despite 10 days of
organism-specific antibiotic therapy, the vegetation enlarged, and
the patient remained septic. At the operation, inspection of the
valve revealed an irregular vegetation on the left coronary cusp
without involvement of the other two leaflets, annulus, or neoaorta.
The vegetation was completely excised with, a 2-mm rim of
homograft valve tissue (Figure 2, A). A 2  1-cm crescent-shaped
piece of bovine pericardium was used to reconstruct the left
coronary cusp with 5-0 polypropylene suture in a running fashion
(Figure 2, B). Intraoperative transesophageal echocardiography
revealed trivial aortic insufficiency. The patient recovered well and
was discharged to a rehabilitation center, where she received
intravenous antibiotics. At 5 months after this latest episode, the
patient remains symptom free, has not resumed intravenous drug
use, and has trivial aortic insufficiency according to transthoracic
echocardiography.
Discussion
PVE is a rare complication after valve replacement for noninfec-
tious causes.5 However, the risk of PVE of a valve that was
originally placed because of endocarditis is at least 7-fold higher,
approaching 10%.1,6 For patients who resume intravenous drug
use, the recurrence rate may exceed 40%.2
Aortic valve repair has been used effectively but sparingly for
treatment of native valve endocarditis.3 For recurrent infections
involving an aortic valve prosthesis with an extensive abscess,
homograft root replacement is the procedure of choice. Homograft
valves are associated with a diminished risk of early PVE,1,6
although a recent meta-analysis revealed that the early protective
resistance to recurrent infection does not persist in the long term.6
For our patient with multiply recurrent PVE, the options were
limited. Prosthetic homograft valve repair was chosen, and al-
though the durability of such a repair is entirely unknown, it
afforded the patient with an opportunity for her infection to clear.
If the patient can avoid intravenous drug use, a more permanent
solution can be offered at a later date should the valve fail. To the
best of our knowledge, valve repair of an aortic homograft has not
been reported previously, but the application of this technique, in
lieu of reoperative homograft root replacement, greatly reduced
both the ischemic time and complexity of the operation. This
probably contributed to the successful outcome to date. We there-
fore believe that valve repair should be considered for patients
with active homograft endocarditis if anatomically feasible.
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Figure 1. Transesophageal echocardiographic image demonstrating 1.5-cm vegetation on left coronary cusp (large
arrow) of aortic homograft. Small arrow indicates uninvolved right coronary cusp. AO, Aorta; LV, left ventricle.
Figure 2. Technique of aortic homograft valve repair. A, Excision of left coronary cusp containing vegetation and
2-mm rim of healthy tissue. B, Placement of bovine pericardial patch to reconstruct cusp.
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Initial experience with a stentless porcine bioprosthesis for right
ventricular outflow tract reconstruction in children
Luca A. Vricella, MD, Michael A. Coady, MD, and Michael D. Black, MD, Stanford, Calif
Postoperative pulmonary regurgitation and stenosis stillremain major determinants of long-term outcome in chil-dren requiring right ventricular outflow tract (RVOT)reconstruction.
Because of relatively low right-sided pressures, mechanical
valves are at high risk for thrombosis, and long-term anticoagula-
tion is disadvantageous in pediatric patients for obvious reasons.1
Because of accelerated calcification, bioprosthetic valves are, on
the other hand, likely to undergo structural valve deterioration in
younger patients.2
The use of a stentless valve design, with improved shear stress
on the valve leaflets, might prevent early valvular calcification.
The Toronto stentless porcine valve (SPV; St Jude Medical, Inc, St
Paul, Minn) incorporates a flexible Dacron ring with lack of an
accompanying aortic wall. We hypothesized that these distinguish-
ing characteristics might allow for improved long-term function
when used in RVOT reconstruction in children.
Clinical Summary
Nine patients (8 male patients and 1 female patient) born with
tetralogy of Fallot underwent RVOT reconstruction with Toronto
SPVs between March 1998 and July 2001. Mean age and weight
were, respectively, 11.2 years (range, 4-17 years) and 41.6 kg
(range, 15.2-83.1 kg). Preoperative patient characteristics and sur-
gical indications are summarized in Table 1. All but one procedure
were reoperative, with surgical indications being RVOT stenosis
(n  4) or pulmonary insufficiency (n  5). Intraoperative trans-
esophageal echocardiography was performed in all patients, and
transthoracic echocardiograms were obtained at various intervals
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Figure 1. Insertion of an SPV in the subannular position within the
RVOT before patch arterioplasty: A, mattress suture securing the
anterior SPV commissural post to the RVOT patch; B, sutures
spacing the posterior posts at 120° distance to protect the right
and left pulmonary ostia; C, continuous proximal suture. The
anterior 120° of the suture line are passed transversely across the
RVOT patch.
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